Secondary effects of Covid vaccines remain limited
Health regulator Swissmedic has so far received 862 reports of suspected adverse reactions following a Covid-19 vaccination in Switzerland. This corresponds to around one case per 1,000 vaccine doses administered.
This content was published on
3 minutes
Keystone-SDA/ts
Español
es
Los efectos secundarios de las vacunas son limitados
“There is no evidence to date of any new safety signals,” Swissmedic said in a statementExternal link on Friday.
The majority of the reports involved more than one reaction (a total of 2,154 reactions, averaging 2.5 per report). The most common were injection site reactions (redness, itching, pain and swelling), fever, headaches, muscle pain and shivering. Cases with these reactions accounted for more than half of the reports (56%).
The average age of those affected was 64.4 (with a range of 16-101); 42.7% were over 75. In two-thirds of the cases women suffered from the side effects.
Three out of ten adverse reaction reports, or 263 cases, were classified as serious. The most common reactions in these cases were fever, shortness of breath, hypersensitivity, anaphylactic reactions, infection with Covid-19, vomiting, dizziness, headache and reactivation of shingles.
Regarding the “infection with Covid-19” cases, Swissmedic said those reports related to cases of Covid-19 where there was a correlation in time with the vaccination. “Since the vaccinated persons had not been tested before they were vaccinated and the human body first needs to build up its protection against the virus, the onset of Covid-19 disease in temporal correlation with vaccination is possible,” it said. “However, there is no causal link with the vaccination. Unlike live vaccines – e.g. those against measles, mumps and rubella (MMR) – Covid-19 vaccines do not contain (attenuated) viruses and cannot therefore trigger Covid-19 disease.”
Some of the “serious” patients, whose average age was 70.6, did require hospital treatment, Swissmedic said. In most cases, however, they were not in danger.
In 70 cases, reactions occurred explicitly after the second vaccination dose.
Some 460 reports were received after vaccination with the Pfizer/BioNTech vaccine and 393 after a Moderna vaccination. In nine cases, the vaccine was not specified.
More
More
Swiss prepare for influx of Covid-19 vaccine doses
This content was published on
The government will receive another 8.1 million doses from April to July, enabling anyone who wants get inoculated by July.
Thirty-seven people died “at differing intervals after receiving the vaccine”, Swissmedic said. These cases were “analysed with particular care”. Their average age was 84 years, and the majority of them had serious pre-existing conditions.
“As far as is known at present, death was caused by conditions such as infections, cardiovascular events or diseases of the lungs and airways that occurred independently of the vaccinations,” it said. “Despite a chronological correlation, there is no concrete evidence to suggest that the vaccination was the cause of death.”
For Swissmedic, the reported adverse reactions do not change the positive benefit-risk profile of the Covid-19 vaccines.
Swissmedic emphasised that the known side effects that are not serious do not have to be reported. These include temporary pain and swelling at the injection site, fatigue, chills, fever, headache and muscle and joint pain.
According to the Federal Office of Public Health, around 1.25 million vaccine doses have been administered in Switzerland up to and including March 21, 2021, and roughly 466,000 people have been fully vaccinated.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss vaccination plan on ‘shaky ground’
This content was published on
Media reports indicate that vaccinating everyone who wants to by summer relies on meeting ambitious vaccine delivery targets in spring.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.